Literature DB >> 7335150

Turnover rate of molecular species of sphingomyelin in rat brain.

F N LeBaron, S Sanyal, F B Jungalwala.   

Abstract

Turnover rate of individual molecular species of sphingomyelin of adult rat brain myelin and microsomal membranes was determined after an intracerebral injection of 100 microCi of [C3H3]choline. Myelin and microsomal membrane sphingomyelins were isolated from the rest of the lipids. The individual molecular species of benzoylated sphingomyelin were separated and quantitated by reversed-phase high performance liquid chromatography. All individual major molecular species of microsomal and myelin sphingomyelin had maximum incorporation at 6 and 15 days, respectively, after the injection. The specific radioactivity of all the various molecular species of both myelin and microsomal sphingomyelin declined at a similar rate after reaching a maximum. There was no significant difference in the turnover rate of short chain (16:0, 18:0) and long chain (greater than 22:0) fatty acid containing sphingomyelin. The average apparent turnover rate of myelin and microsomal sphingomyelin molecular species was about 14-16 days for the fast pool and about 45 days for the slow pool. It is concluded that individual molecular species of sphingomyelin of myelin and microsomal membranes turned over at a similar rate. Thus, turnover rate of sphingomyelin in myelin and microsomal membranes is not affected by the fatty acyl composition of the lipid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7335150     DOI: 10.1007/bf00964414

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

Review 1.  Phase transitions and fluidity characteristics of lipids and cell membranes.

Authors:  D Chapman
Journal:  Q Rev Biophys       Date:  1975-05       Impact factor: 5.318

2.  Metabolism of glycerophospholipids of myelin and microsomes in rat brain. Reutilization of precursors.

Authors:  S L Miller; J A Benjamins; P Morell
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

3.  High-performance liquid chromatography of phosphatidylcholine and sphingomyelin with detection in the region of 200 nm.

Authors:  F B Jungalwala; J E Evans; R H McCluer
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

4.  Turnover of phosphatidylcholine in cell membranes of adult rat brain.

Authors:  J M Pasquini; L Krawiec; E F Soto
Journal:  J Neurochem       Date:  1973-09       Impact factor: 5.372

5.  Separation of molecular species of sphingomyelin and ceramide by argentation and reversed-phase HPLC.

Authors:  M Smith; P Monchamp; F B Jungalwala
Journal:  J Lipid Res       Date:  1981-05       Impact factor: 5.922

6.  Turnover of molecular species of sphingomyelin in microsomes and myelin of rat brain.

Authors:  L Freysz; P Mandel
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

7.  Protein-catalyzed exchange of phosphatidylinositol between rat brain microsomes and myelin.

Authors:  P Ruenwongsa; H Singh; F B Jungalwala
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Synthesis and turnover of cerebrosides and phosphatidylserine of myelin and microsomal fractions of adult and developing rat brain.

Authors:  L W Hayes; F B Jungalwala
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

9.  Metabolism of cellular membrane sulpholipids in the rat brain.

Authors:  A N Davison; N A Gregson
Journal:  Biochem J       Date:  1966-03       Impact factor: 3.857

10.  The turnover of myelin phospholipids in the adult and developing rat brain.

Authors:  F B Jungalwala; R M Dawson
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  3 in total

1.  Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Authors:  Veronique E Miron; Samuel K Ludwin; Peter J Darlington; Andrew A Jarjour; Betty Soliven; Timothy E Kennedy; Jack P Antel
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

2.  A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

Authors:  Marios C Pantzaris; George N Loukaides; Evangelia E Ntzani; Ioannis S Patrikios
Journal:  BMJ Open       Date:  2013-04-17       Impact factor: 2.692

3.  Myelin recovery in multiple sclerosis: the challenge of remyelination.

Authors:  Maria Podbielska; Naren L Banik; Ewa Kurowska; Edward L Hogan
Journal:  Brain Sci       Date:  2013-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.